Lanzamiento Enero 2027

Estudio2018

Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice

Che H, Li Q, Zhang T, Zhang T, Wang D, Yang L, Xu J, Yanagita T, Xue C, Chang Y, Wang Y

Journal of agricultural and food chemistry · 92 citas

Cómo se estudió

Diseño
Estudio en animales (clasificado por nuestro filtro de IA)
Estudiado en
Animales
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Natural Science Foundation of China
Gobierno
Ministry of Education of the People's Republic of China
Gobierno
Japan Society for the Promotion of Science
Gobierno
Government of Shandong Province
Gobierno
Shandong Province
Gobierno
Ministry of Education of the People's Republic of China
Subvenciones
National Natural Science Foundation of China (U1606403); Ministry of Education of the People's Republic of China (201762028); National Natural Science Foundation of China (31330060); Japan Society for the Promotion of Science (16K00890); Government of Shandong Province (U1606403)

Según 6 financiadores declarados.

Publicación

Publicado
2018-04-25 · J Agric Food Chem · vol. 66 · número 19 · págs. 4948–4957
Editorial
American Chemical Society
Citado
150 citas · más que el 97% de estudios similares · 4.7× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
30 trabajos
Acceso
De pago
Áreas de investigación
Antioxidant Activity and Oxidative Stress · Coenzyme Q10 studies and effects · Fatty Acid Research and Health
Palabras clave
Neuroinflammation, Docosahexaenoic acid, Astaxanthin, Morris water navigation task, Oxidative stress, Senile plaques, Pharmacology, Genetically modified mouse, Chemistry, Pathogenesis, Alzheimer's disease, Medicine, Transgene, Biochemistry, Endocrinology, Internal medicine, Fatty acid, Polyunsaturated fatty acid, Hippocampus, Disease
MeSH
animals, mice, transgenic, humans, mice, alzheimer disease, xanthophylls, docosahexaenoic acids, amyloid beta-protein precursor, learning, memory, acylation, female, male, presenilin-1

10 autores

  • Hongxia Che🇨🇳Ocean University of China
  • Qian Li🇨🇳Ocean University of China
  • Tiantian Zhang🇨🇳Ocean University of China
  • Dandan Wang🇨🇳Ocean University of China
  • Lu Yang🇨🇳Ocean University of China
  • Jie Xu🇨🇳Ocean University of China
  • Teruyoshi Yanagita🇯🇵Saga University
  • Changhu Xue🇨🇳Qingdao National Laboratory for Marine Science and Technology; Ocean University of China
  • Yaoguang Chang🇨🇳 · autor de correspondenciaOcean University of China
  • Yuming Wang🇨🇳 · autor de correspondenciaQingdao National Laboratory for Marine Science and Technology; Ocean University of China

Resumen

El texto original del estudio, en el idioma en que se publicó.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with the characteristics of senile plaques, neuroinflammation, neurofibrillary tangles, and destruction of synapse structure stability. Previous studies have verified the protective effects of astaxanthin (AST). However, whether synthesized docosahexaenoic-acid-acylated AST diesters (AST-DHA) could delay AD pathogenesis remains unclear. In the present study, APP/PSEN1 (APP/PS1) double-transgenic mice were administrated with AST and AST-DHA for 2 months. The results of radial 8-arm maze and Morris water maze tests showed that AST-DHA exerted more significant effects than AST in enhancing learning and memory levels of APP/PS1 mice. Further mechanical studies suggested that AST-DHA was superior to AST in regulating the parameters of oxidative stress, reducing tau hyperphosphorylation, suppressing neuroinflammation, and regulating inflammasome expression and activation in APP/PS1 mice. The findings suggested that AST-DHA attenuated cognitive disorders by reducing pathological features in APP/PS1 mice, suggesting that AST-DHA might be a potential therapeutic agent for AD.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.